Target intelligence / Profile preview

Skin barrier integrity

Molecular classification
Other (not a single molecule, receptor, or protein), Physical structure (composed of multiple molecular components), Tissue-level function
01

Overview

The **skin barrier** refers to the composite structure and function provided primarily by the outermost layers of the epidermis—especially the stratum corneum—and associated elements such as intercellular lipids (ceramides, cholesterol), tight junctions in granular layers, cornified envelopes formed from keratinocytes/filaggrin aggregation, desmosomes/corneodesmosomes for cell adhesion, and an acidic pH environment. This multi-layered system protects against environmental insults (physical trauma, pathogens), prevents excessive water loss from within ("IN–OUT" function), maintains optimal hydration/pH for enzymatic activity and microbiome balance ("OUT–IN" protection), and modulates local immune responses. Disruption in any component can lead to increased susceptibility to inflammatory diseases like eczema/atopic dermatitis or ichthyosis vulgaris due to impaired structural proteins such as filaggrin or altered lipid composition. The term "skin barrier/mucosal membrane integrity" is not a canonical molecular target but describes an emergent property resulting from coordinated action among many molecules; thus it is not considered a druggable therapeutic target in itself but rather an endpoint influenced by targeting its constituent proteins/lipids/pathways.[1][2][4][5] Note: This entry is marked **incorrect** because "Skin barrier/mucosal membrane integrity" does not refer to a single molecule/receptor/protein but instead describes an overall tissue-level property dependent on multiple interacting components. For structured data purposes it should be replaced with specific targets such as "Filaggrin," "Ceramide synthase," etc.[2][6]

Other names
Epidermal barrierStratum corneum barrierCutaneous barrierMucosal membrane integrity (when referring to mucosa)
02

Biological functions

Protection against physical, chemical, and biological aggressors[1][3][5]Prevention of transepidermal water loss (TEWL)[1][3]Regulation of skin hydration and pH[1][5]Modulation of immune responses[5]Maintenance of homeostasis with skin microbiota[5]
03

Disease associations

Inflammation (e.g., atopic dermatitis, eczema)[2][4]Infection susceptibility[1][5]Ichthyosis vulgaris and other genetic skin disorders[1][4]

Beyond the preview

Go deeper on Skin barrier integrity.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Skin barrier integrity.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call